IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SPARATORE, ANNA CONCETTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.683
NA - Nord America 6.322
AS - Asia 3.801
SA - Sud America 266
AF - Africa 40
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 24
Totale 20.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.209
GB - Regno Unito 3.342
CN - Cina 1.552
DE - Germania 1.539
IT - Italia 1.492
SE - Svezia 1.059
SG - Singapore 754
RU - Federazione Russa 683
TR - Turchia 413
KR - Corea 316
UA - Ucraina 309
IN - India 285
IE - Irlanda 268
FR - Francia 208
NL - Olanda 197
EU - Europa 185
FI - Finlandia 175
DK - Danimarca 138
VN - Vietnam 133
BR - Brasile 132
ID - Indonesia 92
CO - Colombia 87
HK - Hong Kong 81
CA - Canada 67
PL - Polonia 62
JP - Giappone 55
GR - Grecia 49
AU - Australia 27
BE - Belgio 27
MX - Messico 24
IR - Iran 23
CH - Svizzera 20
AT - Austria 19
ES - Italia 19
PT - Portogallo 17
RO - Romania 17
CR - Costa Rica 15
IQ - Iraq 15
CL - Cile 13
IL - Israele 12
CZ - Repubblica Ceca 10
AR - Argentina 9
PH - Filippine 9
PE - Perù 8
TH - Thailandia 8
TW - Taiwan 8
ZA - Sudafrica 8
PK - Pakistan 7
NG - Nigeria 6
SC - Seychelles 6
UZ - Uzbekistan 6
EC - Ecuador 5
EG - Egitto 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
AZ - Azerbaigian 4
ME - Montenegro 4
NO - Norvegia 4
RS - Serbia 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
BO - Bolivia 3
GE - Georgia 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
MA - Marocco 3
MU - Mauritius 3
MY - Malesia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CI - Costa d'Avorio 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
A1 - Anonimo 1
BD - Bangladesh 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
SV - El Salvador 1
Totale 20.331
Salva come PNG Salva come JPEG
Città #
Southend 3.147
Hanover 747
Seattle 572
Chandler 540
Milan 488
Singapore 439
Princeton 396
Beijing 342
Wilmington 335
Ann Arbor 316
Ashburn 291
Council Bluffs 276
Dublin 265
Fairfield 259
Mountain View 256
Redmond 209
Jacksonville 202
Nanjing 182
Woodbridge 181
Dearborn 171
Santa Clara 152
Frankfurt am Main 132
Sakarya 129
Somerville 118
Des Moines 114
Cambridge 107
Houston 103
Bengaluru 94
Boardman 92
Serra 91
Shenyang 88
Andover 86
Redwood City 86
Bogotá 81
Jinan 71
Grafing 67
Phoenix 65
Hong Kong 60
Nanchang 60
Berlin 56
Hangzhou 53
Guangzhou 51
Jakarta 51
Pisa 51
Shanghai 51
Kent 50
Medford 46
Eitensheim 45
Changsha 43
Seoul 39
Hebei 37
Jiaxing 37
Toronto 37
Warsaw 37
Dong Ket 34
Tianjin 32
Athens 31
Hamburg 31
Istanbul 31
Munich 28
New York 27
San Diego 26
Zhengzhou 25
Bitonto 24
Los Angeles 23
Ningbo 23
Brussels 22
Rome 22
Roxbury 21
Genoa 20
Bühl 19
Fuzhou 19
Lanzhou 19
Helsinki 18
São Paulo 18
Turin 18
San José 15
Washington 15
Fremont 14
Hefei 14
Kunming 14
Monza 14
Norwalk 14
Silver Spring 14
Taizhou 13
Wuhan 13
Auburn Hills 12
Novosibirsk 12
Nuremberg 12
Verona 12
Boston 11
Chicago 11
Haikou 11
Piscataway 11
Quanzhou 11
Sunnyvale 11
Tokyo 11
Vienna 11
Costa Mesa 10
Naples 10
Totale 12.921
Salva come PNG Salva come JPEG
Nome #
Acido acetilsalicilico a rilascio di idrogeno solforato : effetti farmacologici 588
The hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart 412
Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats 341
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 307
How selection was made for a new antimalarial drug candidate : from AM1 to MG3, two novel series of 4-aminoquinoline derivatives 261
ACS6, a Hydrogen sulfide-donating derivative of sildenafil, inhibits homocysteine-induced apoptosis by preservation of mitochondrial function 250
High antiplasmodial activity of novel plasmepsins I and II inhibitors 237
Methanethiosulfonate derivatives as ligands of STAT3-SH2 domain 231
Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats 223
New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors 213
Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain 203
Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis 196
Old and new targets for innovative antimalarial compounds : the different strategies of the Italian Malaria Network 194
S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling 194
Benzimidazole derivatives endowed with potent antileishmanial activity 191
Hydrogen Sulfide Releasing Aspirin, ACS14, Attenuates High Glucose-Induced Increased Methylglyoxal and Oxidative Stress in Cultured Vascular Smooth Muscle Cells 188
H(2)S-Releasing Aspirin Protects against Aspirin-Induced Gastric Injury via Reducing Oxidative Stress 187
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 184
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline : A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial 181
In vivo evaluation of quinolizidinyl-and quinolizidinylalkyl-derivatives of 4-aminoquinoline using the murine malaria model Plasmodium berghei/anopheles stephensi 175
null 175
Design, Synthesis and In Vitro Investigation of Novel Basic Celastrol Carboxamides as Bio-Inspired Leishmanicidal Agents Endowed with Inhibitory Activity against Leishmania Hsp90 171
Antiparasitic activities and toxicities of individual enantiomers of 7-chloro-N-[[(9a)-octahydro-2H-quinolizin-1-yl]methyl]-4-quinolinamine 167
The new H2S-releasing compound ACS94 exerts protective effects through the modulation of thiol homoeostasis 165
Therapeutic effect of hydrogen sulfide-releasing L-dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model 163
Modulation of thiol homeostasis induced by a novel H2S-releasing compound 162
New aryldithiolethione derivatives as potent histone deacetylase inhibitors 157
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative 157
Ability of quinolizidinyl- and quinolizidinylalkyl-derivatives of 4-aminoquinoline to overcome chloroquine resistance 157
Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinoline 156
Novel neuroprotective hydrogen sulfide-releasing L-DOPA derivatives for the treatment of Parkinson disease 155
1-(arylalkyl)quinolizidine derivatives and thio-isosteric analogs as ligands for sigma receptors 153
In vitro and in vivo evaluation and early transitioning studies of novel quinolizidinyl- and quinolizidinylalkyl- derivatives of 4-aminoquinoline with potent antimalarial activity 153
Clofazimine analogs as antimalarial drugs 153
Synthesis and antiplasmodial evaluation of new N-(imidazol-2-yl)-methyl-4-aminoquinolines 152
MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment 152
Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinolines 149
NOVEL ARYLPYRROLYLAMINOQUINOLINES AS POTENT ANTIMALARIAL AGENTS 149
Antiparasitic activity and ADME-tox profile of new 4-aminoquinoline derivatives 148
Hydrogen sulfide releasing molecule {MZe}786 inhibits soluble Flt-1 and prevents preeclampsia in a refined mouse {RUPP} model 148
Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline 147
. 5-Fluorouracil derivatives and their use for the treatment of cancer 147
Pharmacological profile of a novel H2S-releasing aspirin 146
Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs' 145
Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline 144
[4-(2H-1,2,3-benzotriazol-2-yl)phenoxy]alkanoic acids as agonists of peroxisome proliferator-activated receptors (PPARs) 141
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 141
Novel antimalarial aminoquinolines : heme binding and effects on normal or Plasmodium falciparum-parasitized human erythrocytes 139
Identification and screeening of natural and synthetic products with significant antimalarial activity in vitro 138
2-{4-[ω-[4-(2-methoxyphenyl)-1-piperazinyl] alkoxy] phenyl}phthalimides as ligands for some 5-HT, dopamine and adrenergic receptor subtypes 138
New aryldithiolethione derivatives as potent histone deacetylase inhibitors 136
Novel amodiaquine congeners as potent antimalarial agents 135
Novel 4-aminoquinolines : determination of binding and internalization by a new fluorimetric method and effects on human RBC 134
Quinolizidine-derived lucanthone and amitriptyline analogues endowed with potent antileishmanial activity 134
Antiparasitic activity and ADME-Tox profile of new 4-aminoquinoline derivatives 132
COMPOUNDS FOR TREATING METABOLIC SYNDROME 131
Targeting the plasmepsin 4 orthologs of Plasmodium sp with "Double Drug" inhibitors 129
Clofazimine analogs with antileishmanial and antiplasmodial activity 129
Atovaquone-statine "Double-Drugs" with high antiplasmodial activity 128
2-{4-[ω-[4-(2-methoxyphenyl)-1-piperazinyl]alkoxy]phenyl}-2H-benzotriazole s and their N-oxides as ligands for some 5-hydroxytryptamine, dopamine and adrenergic receptor subtypes 128
New sulfurated derivatives of valproic acid with enhanced histone deacetylase enhibitory activity 126
New prostaglandin derivative for glaucoma treatment 125
Sulindac Derivatives for Treatment of Cancer 125
Hydrogen Sulfide Inhibits Human Platelet Aggregation In Vitro in Part by Interfering Gap Junction Channels : Effects of ACS14, a Hydrogen Sulfide-releasing Aspirin 125
ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture 124
Anti-inflammatory activity of S-diclofenac, a novel H2S-releasing diclofenac derivative 122
[3,6-disubstituted 1-lupinylquinoxalin-2(1H)-ones of pharmacological interest. Effect on acquisition and modification of a conditioned avoidance response in rats] 121
Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl)aminoquinoline 121
Epimerization of Lupinine to Epilupinine and viceversa. Reexamination of the Structures of Lupinal and Epilupinal 119
[Synthesis and pharmacologic activity of 3-quinolizidine-1'-yl-5-R-indoles] 119
Quinolizidinyl derivatives as potent inhibitors of acetyl- and butyryl-cholinesterase (ACHE and BCHE) of potential interest for the treatment of Alzheimer's disease 118
Antiprotozoal activity of novel diaryliminophenazines 118
Inhibition of plasmepsin II and IV and antiplasmodial activity of primaquine-statine double drugs 117
THIOSULFONATE ANTI-INFLAMMATORY AGENTS 117
New rosmaricine derivates as anticancer agents 117
Disruption of prostate cancer cell—macrophage—osteoclast crosstalk by a novel TRAF6 inhibitor 117
Pharmacological profile of a novel H2S-releasing aspirin 116
Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation 115
Novel arylpyrrolylaminoquinolines as potent antimalarial agents 115
Scale-up synthesis of MG3, a pyrrolizidinyl 4-aminoquinoline derivative, as novel antimalarial drug candidate 115
Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid 114
Potente attività antimalarica di chinolizidinilalchil-derivati delle 4ammino-chinoline 114
Antimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines 114
Therapeutic potential of new hydrogen sulfide-releasing hybrids 113
Derivatives of 4- or 5-aminosalicylic acid 113
Novel Hydrophilic Riminophenazines as Potent Antiprotozoal Agents 113
Insights on the mechanism of action of novel quinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity 112
Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury 112
ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β-induced cell cytotoxicity 112
Target-Oriented Development Of Novel Antiprotozoal Agents: Celastrol Carboxamides As Inhibitors Of Leishmania Hsp90 112
2-(4-R-phenoxy/phenylthio)alkanoic esters of l-lupinine 111
Hydrogen Sulfide-Releasing NSAIDs Attenuate Neuroinflammation Induced by Microglial and Astrocytic Activation 110
Superior Properties of N-Acetylcysteine Ethyl Ester over N-Acetyl Cysteine to Prevent Retinal Pigment Epithelial Cells Oxidative Damage 110
Synthesis, antimalarial activity, and cellular toxicity of new arylpyrrolylaminoquinolines 109
New sulfurated cinnamic acid derivatives as multitarget anticancer agents 108
Inhibition of Plasmepsins II and IV and Antiplasmodial Activity of Primaquine–Statine Double Drugs 107
Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation : potential for treating Parkinson disease 106
Mechanistic studies on the MPTP inactivation of MAO B 106
CLOFAZIMINE ANALOGS WITH ANTILEISHMANIAL AND ANTIMALARIAL ACTIVITIES 106
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES 104
Totale 15.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020911 0 0 0 0 0 0 0 0 387 361 121 42
2020/20212.380 35 164 166 42 330 166 138 126 278 170 587 178
2021/20222.923 339 215 65 179 243 197 391 202 225 259 194 414
2022/20232.388 400 208 201 255 255 462 68 156 206 32 95 50
2023/20241.529 50 115 108 95 357 86 58 114 34 145 173 194
2024/20252.052 144 311 69 301 289 167 124 466 181 0 0 0
Totale 21.580